The acquisition of CAME will enable Azelis to expand its field of activities into the friction market and it will strengthen its presence in CASE, personal care and rubber & plastic additives (R&PA)
The company has posted net profit of Rs.220.46 crores for the 9 months period ended December 31, 2020.
This is the first patent for UFlex's chemicals business in India and the company will be considering applying for a global patent in due course of time.
This project will be the first of its kind to use waste tires as feedstock for low-carbon, low-sulfur fuel production
The proposed combination of AkzoNobel and Tikkurila would create a strong platform for future growth, better able to serve customers with more innovative and sustainable solutions, building on a shared European heritage
Around 33 women participated in the program.
The company has posted net profit of Rs.13.93 crores for the 9 months period ended December 31, 2020
The company has posted net profit of Rs.15.29 crores for the 9 months period ended December 31, 2020.
With a mix of vaccines targeting different stages of COVID-19, the company is eyeing huge market potential
The phase 3 clinical trial of Sputnik V will be conducted on 1,500 subjects as part of the randomized, double blind, parallel group placebo controlled study in India.
The company has recently been granted a patent for “Fabric and Method of Manufacturing Fabric" by the European Patent office.
The stock has delivered a whopping ~150% returns over the last one year and a large part of the rerating is attributed to greater visibility in the CRAMS segment.
This branding change will allow Nobian to develop its integrated European value chain for essential base chemicals
LANXESS plans to finance the envisaged acquisition with an enterprise value of approximately EUR 70 million out of cash.
Huntsman paid $250 million, subject to customary closing adjustments, in an all-cash transaction funded from available liquidity.
Novasep's viral vector business is an excellent strategic fit as Thermo Fisher continues to expand its capabilities for cell and gene vaccines and therapies globally," said Michel Lagarde, executive vice president, Thermo Fisher.
Promising drug pipeline, focus on gene therapy and innovative digital health solutions will remain the key pillars of Bayer’s pharmaceutical business
MCC has reviewed its business units, and in April of this year will reorganize and consolidate them in alignment with products and market sectors.
In FY 2020-2021 (upto 12th January 2021) Jan Aushadhi Kendras have completed sales of Rs. 484 crores at 7,064 Pradhan Mantri Bhartiya Jan Aushadhi Kendras
This vaccination programme is based on the principles of priority groups to be vaccinated and health care workers both in the government and private sectors including ICDS workers will receive the vaccine during this phase.
Subscribe to our newsletter & stay updated.
